什么是持股变动声明？$Dyne Therapeutics (DYN.US)$ Director Kersten Dirk sold 136.11K shares of common stock on Dec 6, 9, 2024 at an average price of $29.3 for a total value of $3.99 million.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.
